product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
CD39L3/ENTPD3 Antibody (101) [Alexa Fluor Plus 488]
catalog :
NBP2-89707AFP488
quantity :
0.1 ml
price :
569 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
101
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP2-89707AFP488
SKU :
NBP2-89707AFP488
product name :
CD39L3/ENTPD3 Antibody (101) [Alexa Fluor Plus 488]
sizes available :
0.1 ml
description :
The CD39L3/ENTPD3 Antibody (101) [Alexa Fluor Plus 488] from NBP2-89707AFP488 is a 6.7e-05 antibody to . This antibody reacts with human.
target :
CD39L3/ENTPD3
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
101
conjugate :
Alexa Fluor Plus 488
dilution :
ELISA
host :
Rabbit
immunogen :
This antibody was obtained from a rabbit immunized with purified, recombinant Human CD39L3/ENTPD3 (Uniprot#: O75355; Gln44-Pro485).
isotype :
IgG
purity :
Protein A purified
species :
Human
gene symbol :
ENTPD3
applications :
ELISA
extended description :
Recombinant Monoclonal Antibody
USD :
569 USD
product details :
Recombinant Monoclonal Antibody
alt names :
CD39 antigen-like 3, CD39L3EC 3.6.1.5, CD39-like 3, EC 3.6.1, Ecto-apyrase 3, Ecto-ATP diphosphohydrolase 3, Ecto-ATPase 3, Ecto-ATPDase 3, ectonucleoside triphosphate diphosphohydrolase 3, FLJ93839, HB6NTPDase 3, NTPDase-3
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments
